Detalhe da pesquisa
1.
Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA.
J Virol
; 88(10): 5474-90, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24574412
2.
Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers.
JCO Oncol Pract
; 19(4): e542-e549, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758192
3.
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study.
Leuk Lymphoma
; 63(10): 2383-2392, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35730586
4.
The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.
J Virol
; 84(10): 4946-59, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20200245
5.
Alternatively initiated gene 50/RTA transcripts expressed during murine and human gammaherpesvirus reactivation from latency.
J Virol
; 83(1): 314-28, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18971285
6.
Characterization of omental immune aggregates during establishment of a latent gammaherpesvirus infection.
PLoS One
; 7(8): e43196, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22952645
7.
Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency.
J Virol
; 79(8): 5227-31, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15795307